Damir Nemet

890 total citations
53 papers, 474 citations indexed

About

Damir Nemet is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Damir Nemet has authored 53 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 14 papers in Oncology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Damir Nemet's work include Hematopoietic Stem Cell Transplantation (22 papers), Lymphoma Diagnosis and Treatment (11 papers) and Acute Lymphoblastic Leukemia research (10 papers). Damir Nemet is often cited by papers focused on Hematopoietic Stem Cell Transplantation (22 papers), Lymphoma Diagnosis and Treatment (11 papers) and Acute Lymphoblastic Leukemia research (10 papers). Damir Nemet collaborates with scholars based in Croatia, United States and France. Damir Nemet's co-authors include Boris Labar, Mirando Mršić, Dubravka Sertić, Drago Batinić, Nadira Duraković, Ivo Radman, Igor Aurer, Radovan Vrḫovac, Dražen Pulanić and Ana Boban and has published in prestigious journals such as Blood, Cancer and Frontiers in Immunology.

In The Last Decade

Damir Nemet

51 papers receiving 465 citations

Peers

Damir Nemet

HEMAT

ONCOL

GENET

PFM

Dinesh Bhurani India

T. C. M. Morris United Kingdom

Volkan Hazar Türkiye

Hassan B. Alkhateeb United States

C. N. Nair India

G. Fleischhack Germany

Vijay Gandhi Linga India

Mukul Aggarwal India

Vedat Uygun Türkiye

Edythe A. Albano United States

Dinesh Bhurani India

Damir Nemet

186 ×0.8

HEMAT

58 ×0.5

139 ×1.3

ONCOL

134 ×1.4

GENET

71 ×1.1

PFM

Citations per year, relative to Damir Nemet Damir Nemet (= 1×) peers Dinesh Bhurani

Countries citing papers authored by Damir Nemet

Since Specialization

Citations

This map shows the geographic impact of Damir Nemet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Damir Nemet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Damir Nemet more than expected).

Fields of papers citing papers by Damir Nemet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Damir Nemet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Damir Nemet. The network helps show where Damir Nemet may publish in the future.

Co-authorship network of co-authors of Damir Nemet

This figure shows the co-authorship network connecting the top 25 collaborators of Damir Nemet. A scholar is included among the top collaborators of Damir Nemet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Damir Nemet. Damir Nemet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sabol, Ivan, Darija Vranešić Bender, Zinaida Perić, et al.. (2020). Sarcopenia among patients after allogeneic hematopoietic stem cell transplantation and the impact of chronic graft-versus-host disease. Journal of Cancer Research and Clinical Oncology. 146(11). 2967–2978. 6 indexed citations

Duraković, Nadira, Ivan Krečak, Zinaida Perić, et al.. (2016). Glycoprotein YKL-40: a novel biomarker of chronic graft-vs-host disease activity and severity?. Croatian Medical Journal. 57(3). 239–246. 2 indexed citations

Čeović, Romana, Dražen Pulanić, Ivana Ilić, et al.. (2016). High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host disease. Croatian Medical Journal. 57(3). 229–238. 16 indexed citations

Grubić, Zorana, et al.. (2016). The effect of HLA allele and haplotype polymorphisms on donor matching in hematopoietic stem cell transplantation – Croatian experience. Human Immunology. 77(12). 1120–1127. 4 indexed citations

Smith, Sean R., et al.. (2016). Joint and fascial chronic graft-vs-host disease: correlations with clinical and laboratory parameters. Croatian Medical Journal. 57(3). 266–275. 8 indexed citations

Pulanić, Dražen, Maja Pučić‐Baković, Marija Pezer, et al.. (2016). Potential of glycosylation research in graft versus host disease after allogeneic hematopoietic stem cell transplantation. Biochimica et Biophysica Acta (BBA) - General Subjects. 1860(8). 1615–1622. 6 indexed citations

Batinić, Josip, Zinaida Perić, James I. Last, et al.. (2015). Immunoglobulin heavy/light chain analysis enhances the detection of residual disease and monitoring of multiple myeloma patients. Croatian Medical Journal. 56(3). 263–271. 10 indexed citations

Nemet, Damir. (2012). Advances in treatment of multiple myeloma. 18(100). 1 indexed citations

Nemet, Damir, et al.. (2011). Two different dosing regimens of human recombinant erythropoietin beta during preoperative autologous blood donation in patients having hip arthroplasty. International Orthopaedics. 36(4). 703–709. 14 indexed citations

10.

Batinić, Drago, et al.. (2011). Large volume leukapheresis: Efficacy and safety of processing patient’s total blood volume six times. Transfusion and Apheresis Science. 44(2). 139–147. 26 indexed citations

11.

Grčević, Danka, Rajko Kušec, Nataša Kovačić, et al.. (2009). Bone morphogenetic proteins and receptors are over-expressed in bone-marrow cells of multiple myeloma patients and support myeloma cells by inducing ID genes. Leukemia Research. 34(6). 742–751. 25 indexed citations

12.

Batinić, Drago, et al.. (2008). Biological features and outcome of biphenotypic acute leukemia. Hematology/Oncology and Stem Cell Therapy. 1(4). 225–230. 7 indexed citations

13.

Dai, Hui, Ivo Radman, Boris Labar, et al.. (2006). The Value of F-18 FDG Triple-Head Coincidence PET in the Posttreatment Evaluation of Patients With Lymphoma. Clinical Nuclear Medicine. 31(5). 275–278. 2 indexed citations

14.

Nemet, Damir, Ivo Radman, Igor Aurer, et al.. (2003). High-Dose Ifosfamide and Mitoxantrone (HDIM) as Cytoreductive and Mobilisation Protocol for Relapsed and Refractory Lymphoma. Blood. 1 indexed citations

15.

Sučić, Mirna, Renata Zadro, Boris Labar, et al.. (2002). Acute Promyelocytic Leukemia M3: Cytomorphologic, Immunophenotypic, Cytogenetic, and Molecular Variants. Journal of Hematotherapy & Stem Cell Research. 11(6). 941–950. 23 indexed citations

16.

Sučić, Mirna, et al.. (1998). Relation between urinary cytology abnormalities and cyclosporine a therapy in bone marrow transplant recipients. Renal Failure. 20(4). 613–620. 2 indexed citations

17.

Petrovečki, Mladen, Damir Nemet, Tatjana Kolevska, & Matko Marušić. (1995). Granulocyte-Monocyte Colony Forming Unit Content of Autologous Bone Marrow Transplants in Patients with Haematological Malignancy. Clinical Chemistry and Laboratory Medicine (CCLM). 33(10). 687–692. 1 indexed citations

18.

Labar, Boris, et al.. (1994). High Incidence of Conservative RAS Mutations in Acute Myeloid Leukemia. Acta Haematologica. 92(3). 123–125. 3 indexed citations

19.

Sučić, Mirna, Branka Užarević, Drago Batinić, et al.. (1993). Correlation of morphological FAB classification and immunophenotyping: Value in recognition of morphological, cytochemical and immunological characteristics of mixed leukaemias. European Journal of Cancer. 29(8). 1167–1172. 7 indexed citations

20.

Tindle, Robert W., et al.. (1989). Expression of haematopoietic progenitor cell-associated antigen BI-3C5/CD34 in leukaemia. Leukemia Research. 13(1). 83–85. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact